

NCT03404479 comparison:

Summary:
CHIA has 47 criteria while your personal folder has 47 criteria
Total found criteria: 47/47
Total not Found: 0/47
Total Extra: 6
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Subjects who voluntarily consented, after          │ Subjects who voluntarily consented, after          │
│ listening enough explanation for this study and    │ listening enough explanation for this study and    │
│ investigational product                            │ investigational product                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Adult over 50 years of age                         │ Adult over 50 years of age                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ At least one of the knee pain VAS score is 40mm or │ At least one of the knee pain VAS score is 40mm or │
│ more                                               │ more                                               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients who require medication for more than 12   │ Patients who require medication for more than 12   │
│ weeks due to osteoarthritis symptoms               │ weeks due to osteoarthritis symptoms               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Those who are able to follow the requirements of   │ Those who are able to follow the requirements of   │
│ this clinical trial, such as being able to trace   │ this clinical trial, such as being able to trace   │
│ during the clinical trial period and to read and   │ during the clinical trial period and to read and   │
│ write the VAS questionnaire                        │ write the VAS questionnaire                        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Those who weigh more than 40kg                     │ Those who weigh more than 40kg                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Secondary knee osteoarthritis                      │ Secondary knee osteoarthritis                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Other inflammatory Knee Osteoarthritis (e.g. gout, │ Other inflammatory Knee Osteoarthritis (e.g. gout, │
│ rheumatoid arthritis, etc.)                        │ rheumatoid arthritis, etc.)                        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients presenting with gastroesophageal reflux   │ Patients presenting with gastroesophageal reflux   │
│ disease, peptic ulcer                              │ disease, peptic ulcer                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Helicobacter infected patients who have not been   │ Helicobacter infected patients who have not been   │
│ treated for eradication (recruitment if negative   │ treated for eradication (recruitment if negative   │
│ in re-examination after treatment)                 │ in re-examination after treatment)                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Short bowel syndrome that can cause inflammatory   │ Short bowel syndrome that can cause inflammatory   │
│ bowel disease (ulcerative colitis, Crohn's         │ bowel disease (ulcerative colitis, Crohn's         │
│ disease) and drug absorption disorder              │ disease) and drug absorption disorder              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Intestinal obstruction syndrome                    │ Intestinal obstruction syndrome                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Unexplained abdominal pain                         │ Unexplained abdominal pain                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ ALT(Alanine aminotransferase) level of liver       │ ALT(Alanine aminotransferase) level of liver       │
│ function test exceeded 5 times of reference range  │ function test exceeded 5 times of reference range  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Total bilirubin level exceeded 2 mg / dL           │ Total bilirubin level exceeded 2 mg / dL           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Serum albumin level less than 2 g / dL             │ Serum albumin level less than 2 g / dL             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Ascites                                            │ Ascites                                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Hepatic encephalopathy                             │ Hepatic encephalopathy                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Hepatitis B, hepatitis C (excluding healthy        │ Hepatitis B, hepatitis C (excluding healthy        │
│ carriers) or HIV positive                          │ carriers) or HIV positive                          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ MDRD(Modification of Diet in Renal Disease)        │ MDRD(Modification of Diet in Renal Disease)        │
│ Estimated Glomerular filtration rate less than 60  │ Estimated Glomerular filtration rate less than 60  │
│ mL / m2                                            │ mL / m2                                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with hyperkalemia (over 5.5 meq / L)      │ Patients with hyperkalemia (over 5.5 meq / L)      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ history of asthma, acute rhinitis, nasal polyps,   │ history of asthma, acute rhinitis, nasal polyps,   │
│ angioedema, urticaria or allergic reactions to     │ angioedema, urticaria or allergic reactions to     │
│ aspirin or other non-steroidal anti-inflammatory   │ aspirin or other non-steroidal anti-inflammatory   │
│ drugs(including COX-2 inhibitors)                  │ drugs(including COX-2 inhibitors)                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Malignant tumors other than basal cell or squamous │ Malignant tumors other than basal cell or squamous │
│ cell carcinoma of the skin, CIN(Cervical           │ cell carcinoma of the skin, CIN(Cervical           │
│ Intraepitherial Neoplasia) and CIS(Carcinoma in    │ Intraepitherial Neoplasia) and CIS(Carcinoma in    │
│ situ) of the cervix, and intraepithelial carcinoma │ situ) of the cervix, and intraepithelial carcinoma │
│ of other areas Within 5 years of consent date      │ of other areas Within 5 years of consent date      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Medical history of hypersensitivity to the         │ Medical history of hypersensitivity to the         │
│ components of the investigational products. (The   │ components of the investigational products. (The   │
│ components of test drug 1 and 2, including the     │ components of test drug 1 and 2, including the     │
│ Rhein-based drug)                                  │ Rhein-based drug)                                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with an allergic reaction to sulfonamide  │ Patients with an allergic reaction to sulfonamide  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with galactose intolerance, lapp lactase  │ Patients with galactose intolerance, lapp lactase  │
│ deficiency or glucose-galactose malabsorption      │ deficiency or glucose-galactose malabsorption      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subjects who have not reached the prescribed       │ Subjects who have not reached the prescribed       │
│ period after receiving contraindicated medication  │ period after receiving contraindicated medication  │
│ or treatment before participation in this clinical │ or treatment before participation in this clinical │
│ trial                                              │ trial                                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients receiving contraindicated medication      │ Patients receiving contraindicated medication      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Alcohol and other drug abuse cases based on 6      │ Alcohol and other drug abuse cases based on 6      │
│ months before screening                            │ months before screening                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Pregnant women or nursing mothers who are not      │ Pregnant women or nursing mothers who are not      │
│ willing to stop breastfeeding                      │ willing to stop breastfeeding                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ (1) Menopause (non-therapy-induced amenorrhea of   │ (1) Menopause (non-therapy-induced amenorrhea of   │
│ more than 12 months) Female                        │ more than 12 months) Female                        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ (2) Female infertility due to surgery (no ovaries  │ (2) Female infertility due to surgery (no ovaries  │
│ and / or uterus)                                   │ and / or uterus)                                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ (3) If you have sexual intercourse with only one   │ (3) If you have sexual intercourse with only one   │
│ male partner who has been confirmed to have no     │ male partner who has been confirmed to have no     │
│ semen after fertilization                          │ semen after fertilization                          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ (4) Female subjects who agreed to abstinence       │ (4) Female subjects who agreed to abstinence       │
│ during the clinical trial period                   │ during the clinical trial period                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ If the subject is assured of an abstinence         │ If the subject is assured of an abstinence         │
│ throughout the trial period.(e.g. clergy)          │ throughout the trial period.(e.g. clergy)          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ However, intermittent abstinence (eg,              │ However, intermittent abstinence (eg,              │
│ contraception using ovulation period,              │ contraception using ovulation period,              │
│ symptothermal) or coitus interrupts is not a case  │ symptothermal) or coitus interrupts is not a case  │
│ of consent for abstinence                          │ of consent for abstinence                          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ (5) For women of childbearing age, the following   │ (5) For women of childbearing age, the following   │
│ methods or methods of contraception use the        │ methods or methods of contraception use the        │
│ effective method of contraception to be used       │ effective method of contraception to be used       │
│ during the period of this clinical trial           │ during the period of this clinical trial           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Oral contraceptive                                 │ Oral contraceptive                                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ The contraceptive patch                            │ The contraceptive patch                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Intra uterine device (IUD)                         │ Intra uterine device (IUD)                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ contraceptive implant                              │ contraceptive implant                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ contraceptive injection                            │ contraceptive injection                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ intrauterine hormonal apparatus                    │ intrauterine hormonal apparatus                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Tubal ligation and infertility surgery             │ Tubal ligation and infertility surgery             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ If 30 days have not elapsed after the date of      │ If 30 days have not elapsed after the date of      │
│ signing of the previous clinical trial or          │ signing of the previous clinical trial or          │
│ currently participating in other clinical trials   │ currently participating in other clinical trials   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients who are scheduled for surgery during the  │ Patients who are scheduled for surgery during the  │
│ clinical trial period or who have difficulties in  │ clinical trial period or who have difficulties in  │
│ completing the protocol during this clinical trial │ completing the protocol during this clinical trial │
│ due to other reasons                               │ due to other reasons                               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ In addition to the above, other diseases that the  │ In addition to the above, other diseases that the  │
│ investigator judges to be inappropriate            │ investigator judges to be inappropriate            │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒══════════════════════════════════════════════════════════════════════════════════════════════╕
│ Extra Personal Criteria                                                                      │
╞══════════════════════════════════════════════════════════════════════════════════════════════╡
│ Female who do not fall into one or more of the following categories(In other words, only the │
│ following female can participate:)                                                           │
├──────────────────────────────────────────────────────────────────────────────────────────────┤
│ ③ Crepitus                                                                                   │
├──────────────────────────────────────────────────────────────────────────────────────────────┤
│ Must have minimum age of 50 Years                                                            │
├──────────────────────────────────────────────────────────────────────────────────────────────┤
│ ② Morning stiffness \<30 minutes                                                             │
├──────────────────────────────────────────────────────────────────────────────────────────────┤
│ ① Age\> 50 years                                                                             │
├──────────────────────────────────────────────────────────────────────────────────────────────┤
│ Meets the ACR(American College of Rheumatology) criteria for diagnosis. (1) Confirmation of  │
│ osteophytes on radiographic inspection. (2) One or more of the following three items         │
╘══════════════════════════════════════════════════════════════════════════════════════════════╛